Phase II trial of hypofractionated intensity modulated radiotherapy to 60 Gy in 10 fractions with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme

Authors
Category Primary study
JournalInternational Journal of Radiation Oncology Biology Physics
Year 2011
This article has no abstract
Epistemonikos ID: 84be662372e7d1f299bd9dc8bc57a35a1cc32b88
First added on: Feb 04, 2025